Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special
Leuven, BELGIUM, Boston, MA, US - April 27, 2023 - 7:00 pm CET - Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies,
Regulated Information Leuven, BELGIUM, Boston, MA, US – April 24, 2023 – 8.00 PM CET Oxurion NV a biopharmaceutical company developing next generation standard of care. | April 24, 2023
ST. JOHN S, NL, April 17, 2023 /CNW/ - Aurion Resources Ltd. announces that its common shares are now eligible for electronic clearing and settlement in the United States through the. | April 17, 2023
Regulated Information Leuven, BELGIUM, Boston, MA, US - April 14, 2023 - 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic